0001127602-23-016225.txt : 20230518
0001127602-23-016225.hdr.sgml : 20230518
20230518201646
ACCESSION NUMBER: 0001127602-23-016225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230518
DATE AS OF CHANGE: 20230518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hykes Andrew
CENTRAL INDEX KEY: 0001806431
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39293
FILM NUMBER: 23937701
MAIL ADDRESS:
STREET 1: C/O INARI MEDICAL, INC.
STREET 2: 9 PARKER AVENUE, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inari Medical, Inc.
CENTRAL INDEX KEY: 0001531048
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 452902923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-923-4747
MAIL ADDRESS:
STREET 1: 6001 OAK CANYON, SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: Inceptus Newco1 Inc.
DATE OF NAME CHANGE: 20110923
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-05-16
0001531048
Inari Medical, Inc.
NARI
0001806431
Hykes Andrew
C/O INARI MEDICAL, INC.
6001 OAK CANYON
IRVINE
CA
92618
1
1
President and CEO
0
Common Stock
2023-05-16
4
S
0
818
70.87
D
549466
D
Common Stock
2023-05-16
4
S
0
16945
70.87
D
532521
D
Common Stock
2023-05-16
4
S
0
153
70.87
D
532368
D
Common Stock
2023-05-17
4
S
0
16079
69.19
D
516289
D
Common Stock
2023-05-17
4
S
0
2630
69.19
D
513659
D
Common Stock
2023-05-17
4
S
0
51
69.19
D
513608
D
Common Stock
1550
I
By Child 1
Common Stock
1550
I
By Child 2
Common Stock
1550
I
By Child 3
Common Stock
1000
I
By Spouse
Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the distribution and settlement of previously vested Restricted Stock Units (RSUs). The sale to cover transactions were irrevocably agreed to in writing by the Reporting Person prior to the distribution of the RSUs to satisfy the tax withholding obligations and do not represent a discretionary transaction by the Reporting Person.
This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $69.07 to $69.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $70.27 to $71.25. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Angela Ahmad, attorney-in-fact for Andrew Hykes
2023-05-18